Vital Farms, Inc.

VITL

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Driehaus Capital Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Position Trend

Feb 13, 2026

$16.6M

1 fund

Feb 17, 2026

$8.2M

1 fund

-50% total institutional value over 2 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 257,178Value: $8.2M

**Signal Note: Driehaus Growth Entry into VITL** Driehaus Capital's $8.2M initiation in Vital Farms signals conviction in the pasture-raised egg category as a growth consumer staple, though this represents a non-core biotech position for the typically pharma-focused fund. The move likely reflects confidence in VITL's margin expansion and distribution scaling rather than pipeline catalysts, suggesting appetite for profitable food-tech plays within a diversified growth mandate.

Eventide Asset ManagementNEWFeb 13, 2026

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AXON2 funds NVDA2 funds VEEV2 funds VCYT2 funds LBRT2 funds RMBS2 funds UNP2 funds LITE

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

**Signal Note: Eventide initiates $16.6M stake in Vital Farms (VITL)** This is a values-based allocation rather than a biotech signal—Vital Farms is a food company specializing in pasture-raised eggs and meat, not a therapeutic developer. Eventide's entry likely reflects their ESG/ethical investment mandate around animal welfare and sustainable agriculture rather than clinical or commercial biotech catalysts. This position should not be interpreted as predictive signal regarding drug development, regulatory approvals, or biotech sector momentum.